Category: Impella

Minimizing Hemolysis

Impella Position is Key Marvin Slepian, MD, who specializes in blood rheology, discusses the nature and causes of hemolysis as well as how to prevent and detect hemolysis. Dr. Slepian is a professor of medicine & biomedical engineering and a Regents professor at the University of Arizona. Dr. Slepian explains that all mechanical circulatory support … Continue reading “Minimizing Hemolysis”

Information for Physicians: Medical Office Review of Dhruva et al.

On February 10, the Dhruva et al. paper analyzing CATH PCI and Chest Pain registry data published in JAMA. This paper has similar conclusions to Dr. Dhruva’s presentation on this same topic in November 2019 at the American Heart Association conference. The Abiomed Medical Office has reviewed the Dhruva paper and supplement and identified a number of … Continue reading “Information for Physicians: Medical Office Review of Dhruva et al.”

Managing Impella® Position

Using Imaging and the AIC for Positioning Jo Kajewski, an Advanced Impella Trainer, uses the Abiomed® simulator to show what a baseline echo should look like for patients on Impella support and how to handle two Impella positioning alarms using the Automated Impella Controller (AIC) and imaging. A baseline echo for a patient on Impella … Continue reading “Managing Impella® Position”

Clinical Research

PROTECT IV Randomized Controlled Trial RECOVER IV Randomized Controlled Trial STEMI DTU Randomized Controlled Trial National Cardiogenic Shock Initiative (NCSI) Study DanGer Shock Randomized Controlled Trial FDA Post-Approval Studies PROTECT IV Randomized Controlled Trial The intent of the PROTECT IV Randomized Controlled Trial (RCT) is to leverage and validate the best practices learned from the … Continue reading “Clinical Research”

Impella® Patient Management

Questions to Ask When Caring for an Impella® Patient Jason Richard, an advanced Impella® trainer at Abiomed, reviews questions to ask when taking over care of a patient with an Impella heart pump. Knowing the answers to these questions can make the transition of care safer and smoother for your patients. Which Impella device was … Continue reading “Impella® Patient Management”

PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella Support in High-risk PCI

Looking at the data from the PROTECT Series—PROTECT I1, PROTECT II RCT2, and PROTECT III—William O’Neill, MD, medical director of the Center for Structural Heart Disease at Henry Ford Hospital believes that “the totality of clinical data in favor of Impella supported high-risk PCI allows interventional cardiologists to be confident they are using the optimal … Continue reading “PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella Support in High-risk PCI”

Publication Review: Amin Analysis on Impella and IABP

Review of Trends, Variation and Outcomes in Impella® Use Dr. Seth Bilazarian, Abiomed’s Chief Medical Officer, provides a review of the observational analysis published in Circulation and presented at AHA 2019 by Amin, et al., comparing Impella to IABP. Dr. Bilazarian notes that the study is an observational, non-FDA audited analysis that is fundamentally flawed … Continue reading “Publication Review: Amin Analysis on Impella and IABP”